Abstract
Finding the best treatment for a migraine patient is often a problem in clinical practice since the condition is very common and disabling. The drugs most commonly used for migraine prophylaxis are beta-blockers, calcium antagonist and serotonin modulators. Recently, several double-blind trials have affirmed the efficacy of valproic acid in migraine prophylaxis: the valproic acid is especially useful when migraine occurs in patients with epilepsy, anxiety disorders, or bipolar disorder.
| Original language | Italian |
|---|---|
| Pages (from-to) | 25-27 |
| Number of pages | 3 |
| Journal | Bollettino - Lega Italiana contro l'Epilessia |
| Issue number | 95-96 SUPPL. 1 |
| Publication status | Published - 1996 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
Cite this
II ruolo del valproato di sodio nella profilassi dell'emicrania. / Cortelli, P.
In: Bollettino - Lega Italiana contro l'Epilessia, No. 95-96 SUPPL. 1, 1996, p. 25-27.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - II ruolo del valproato di sodio nella profilassi dell'emicrania
AU - Cortelli, P.
PY - 1996
Y1 - 1996
N2 - Finding the best treatment for a migraine patient is often a problem in clinical practice since the condition is very common and disabling. The drugs most commonly used for migraine prophylaxis are beta-blockers, calcium antagonist and serotonin modulators. Recently, several double-blind trials have affirmed the efficacy of valproic acid in migraine prophylaxis: the valproic acid is especially useful when migraine occurs in patients with epilepsy, anxiety disorders, or bipolar disorder.
AB - Finding the best treatment for a migraine patient is often a problem in clinical practice since the condition is very common and disabling. The drugs most commonly used for migraine prophylaxis are beta-blockers, calcium antagonist and serotonin modulators. Recently, several double-blind trials have affirmed the efficacy of valproic acid in migraine prophylaxis: the valproic acid is especially useful when migraine occurs in patients with epilepsy, anxiety disorders, or bipolar disorder.
KW - Cephalalgia
KW - Migraine
KW - Sodium valproate
KW - Therapy
UR - http://www.scopus.com/inward/record.url?scp=0030378621&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030378621&partnerID=8YFLogxK
M3 - Articolo
AN - SCOPUS:0030378621
SP - 25
EP - 27
JO - Bollettino - Lega Italiana contro l'Epilessia
JF - Bollettino - Lega Italiana contro l'Epilessia
SN - 0394-560X
IS - 95-96 SUPPL. 1
ER -